The header image of vintage Pfizer vaccine vials for today’s offering is courtesy of Dreamstime and Google Images.
Health Friday is a series devoted to Big Pharma, vaccines, general health, and associated topics. As today’s offering speaks to the modRNA COVID-19 “vaccines”, Yours Truly dedicates it to all persons, of whatever age or location, who have passed away from the negative effects of these “vaccines” that they had in the body. May they rest in eternal Peace.
There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated content. To the best of her knowledge and belief, there is none, except perhaps for AI-generated images within items that are linked in the post. If readers wish to post AI-generated content to today’s discussion thread, they must cite their source. Thank you.
Please refer to Part One of this two-part set, found here: https://www.theqtree.com/2025/11/07/health-friday-11-7-2025-open-thread-whats-going-on-at-pfizer-biontech-part-one/, regarding recent activities of PfizerUSA (also known as Pfizer), the United States-based co-partner of Pfizer-BioNTech. Today’s presentation will discuss some of the activities of the other co-partner, Germany-based BioNTech. Of necessity, some of today’s presentation will include items related to Pfizer (PfizerUSA.)
The current “pipeline” for the BioNTech product line is found here: https://www.biontech.com/int/en/home/pipeline-and-products/pipeline.html. The full PDF of the “pipeline” is found here: https://www.biontech.com/content/dam/biontech-corporate/global/pdf/home/pipeline-and-products/pipeline/assets/BioNTech-Clinical-Pipeline-EN-Q3.pdf, “Status: November 3, 2025.” A screenshot of the Infectious Diseases section of this pipeline is below:

Note the Collaborator / Partner listings on the far right of the image. There are two entities involving Bill Gates: the Gates Foundation; and, CEPI. There are two mentions of Pfizer (also known as PfizerUSA.) There is one mention of the University of Pennsylvania. Note also the BioNTech rights listings: the company fully owns the mRNA (modRNA) “vaccines” under development for Tuberculosis, for Malaria, and for Monkeypox (Mpox.) More on the Fosun Pharma collaboration / partnership will be presented further below in today’s post.
It appears that the modRNA-based “combo vaccine” for COVID-19 + influenza, also known as either BNT162b2 + BNT161, or as tozinameran + famtozinameran, is actually being developed and tested by BioNTech, with PfizerUSA (Pfizer) as a kind of “stand-by” or “silent” co-partner. Please see the screenshots below, from registered clinical trials information, per https://clinicaltrials.gov/:



**** NONE of these clinical trials have a true Control Group (study subjects injected with a plain saline solution “placebo vaccine.”)
BioNTech is ALSO working on a “new” version of of the modRNA COVID-19 “vaccine”, BNT162b2. However, the only BioNTech listing is this: https://clinicaltrials.biontech.com/trials/C4591076, which “translates” to the NCT07069309 clinical trial referenced above. “C459” is the prefix for Pfizer-BioNTech clinical trials for their modRNA COVID-19 “vaccines” — for example, the huge C4591001 original clinical trial for BNT162b1 / BNT162b2 / BNT162b3, from which BNT162b2 was the “vaccine candidate” chosen by the company in the late summer/early fall of 2020 to proceed through the Emergency Use Authorization applications in the United States and in the EU / Scandinavia.
The question Yours Truly has regarding the “new COVID-19 “vaccine candidate” being used in NCT07069309: Is this “new COVID-19 vaccine candidate” ALSO being used in the clinical trial NCT06821061, also listed above? The modRNA COVID-19 “vaccine” called Investigational COVID-19 Vaccine per the Researcher View of NCT06821061?
Gentle reader, does one see how this aspect of the modRNA “vaccine” game works? BioNTech (the co-partner of PfizerUSA/Pfizer) comes up with a “new vaccine candidate” for COVID-19 — a “new vaccine candidate” which, in reality, is for the current circulating virus variant, LP.8.1. — and appears to use it it as an Investigational COVID-19 Vaccine in one clinical trial (NCT068210161): while, at the same, time, also using this same injectable in another clinical trial (NCT07069309)? How many study subjects in either clinical trial were told of this?
—————————————————————————-
And now, a dive into the “collaborators”, and what may be termed “the other partners”, the “investments partners”, and other entities that are involved with Pfizer-BioNTech, either with PfizerUSA(Pfizer), or with BioNTech. Yours Truly begins with the “active partners” list of PfizerUSA (Pfizer): https://www.pfizer.com/partners/venture-investments/our-portfolio. Below is a screenshot from this article regarding one of these “venture investments partners” — Saama:

What the above article does not mention is the fact that PfizerUSA (Pfizer), along with a group of other healthcare entities, acquired a majority stake in Saama back in October, 2021: https://carlyle.com/media-room/news-release-archive/carlyle-and-leading-healthcare-focused-venture-funds-announce-investment-saama, 20 October 2021. A screenshot from this article is below:

On the other hand, PfizerUSA (Pfizer), wanting to enter more fully into the weight-loss drug marketplace, began acquisition talks with a company called Metsera in August 2025. Metsera is developing a GLP-1 based weight-loss drug, MET-097i, a GLP-1 drug. GLP-1 drugs (Glucagon-like Peptide 1) drugs are designed to lower blood sugar in people taking them, thus (theoretically) leading to weight loss. However, another company, Novo Nordisk, also wanted to acquire Metsera, and, at one point, was working on an “agreement in principle” with the company. This led to a “battle of offers” for Metsera between Pfizer and Novo Nordisk, leading to a lawsuit filed by Pfizer on 1 November 2025 against Metsera and against Novo Nordisk’s offers to Metsera (https://sbj.net/stories/pfizer-sues-metsera-novo-nordisk,101765, Springfield Business Journal, 3 November 2025.) It also appears that Pfizer possibly contacted the United States Federal Trade Commission about the situation — with the result that Novo Nordisk backed away due to a letter sent to the company by the FEC; and, Pfizer, then having the “green light”, could move forward with the acquisition deal for Metsera (https://www.fiercebiotech.com/biotech/pfizer-beats-out-novo-10b-agreement-buy-metsera, Eric Sagonowsky, 8 November 2025.)
Gentle reader, does one see how this aspect of the game is played? It appears that PfizerUSA (Pfizer) gets the United States Federal Trade Commission involved in blocking a deal that a rival company (Novo Nordisk) is working on, in order for Pfizer to acquire the target company?
—————————————————————————
Meanwhile, what of the “collaborators” and “partners” with BioNTech, other than their co-partner, PfizerUSA (Pfizer)? Following is a “snapshot” of this situation:
BioNTech and CEPI (Gates Foundation) are “partnered” in expanding mRNA “vaccine” research, development, and manufacturing, in Kigali, Rwanda: https://cepi.net/biontech-and-cepi-expand-partnership-strengthen-africas-mrna-vaccine-ecosystem, 28 May 2024. A screenshot of the summary from this article is below:

This article emanated from Mainz, Germany, and Oslo, Norway.
**** Note also the use of a new term: “mRNA vaccine ecosystem.” Gentle reader, does one see how this aspect of the game is played? First, create the “problem” (the COVID-19 virus); Second, create the “solution” (modRNA COVID-19 “vaccines”); Third, convince / coerce / frighten / gaslight, billions of people into taking this unproven gene-therapy technology; Fourth, create an “mRNA vaccine ecosystem” in which endless types of mRNA-based / modRNA-based “vaccines” are created and administered to the convinced / coerced / frightened / gaslighted, billions of people as part of the “mRNA vaccine ecosystem”, with the underlying “passive-aggressive threat” of “people must take these “vaccines”, otherwise they would likely get very sick and/or die”.
Yours Truly now turns to the “partnership” between BioNTech and the Communist China-based pharmaceutical company, Fosun Pharma.
Fosun Pharma, also known as Shanghai Fosun Pharmaceutical (Group) Co., Ltd., was founded in 1994. The company has since “spun off” into other related entities, such as Fosun International, and https://fosunpharmausa.com/. Lest there is any doubt that the Chinese Communist Party holds a significant stake in Fosun Pharma, please see this: https://en.fosun.com/Upload/File/202104021739947_5055.pdf, “Corporate Social Responsibility Report – Fosun”, for the year 2012. A graphic from Page 11 of this report is below:

The Wikipedia entry on Fosun Pharma is here: https://en.wikipedia.org/wiki/Fosun_Pharma.
However, it also appears that Guo Guangchang, founder and chairman of Fosun International, has run afoul of the Chinese government at least twice. He “disappeared” in 2015 and in 2017, only to “resurface” after what appears to have been detention and interrogation (for the 2015 “disappearance”, at least) by Chinese authorities: https://variety.com/2015/biz/asia/missing-chinese-executive-released-1201660214/, Patrick Frater, 13 December 2015.
Fosun Pharma and BioNTech went into partnership regarding the development and distribution of BNT162b2 in Communist China. Please the screenshot from the Wikipedia entry regarding this, below:

Please refer also to the BioNTech “pipeline” graphics further above in today’s offering. Fosun Pharma is listed in the Infectious Diseases section as Collaborator / Partner with BioNTech regarding the development and distribution of the modRNA COVID-19 “vaccine” BNT162b2 (now known as COMIRNATY.)
The Fierce Pharma story regarding the Fosun Pharma – BioNTech “partnership” and BNT162b2 is here: https://www.fiercepharma.com/manufacturing/biontech-fosun-pharma-eye-1b-doses-covid-19-vaccine-capacity-new-china-jv, Angus Liu, 10 May 2021. A screenshot from this article is below:

In addition, Fosun Pharma is also “partnering” with PfizerUSA (Pfizer) in the manufacture of a generic form of Paxlovid (owned by Pfizer) for international use: https://medicinepatientpool.org/story-post/fosun-pharmas-global-impact-expanding-access-to-covid-19-treatments-and-beyond-through-voluntary-licensing-with-mpp, 22 November 2024. This sublicense agreement with Medicine Patient Pool (MPP) was signed in March 2022. MPP is, in turn, a division of Unitaid (https://unitaid.org/.) More information regarding MPP is here: https://medicinepatientpool.org/who-we-are/about-us.
Gentle reader, does one see how this aspect of the game is played? The Big Pharma company “creates partnerships” or “sublicensing agreements” with other companies around the world to push the drugs and / or “vaccines” that the Big Pharma company creates and manufactures. Smaller pharmaceutical companies; alternative treatment entities and their products; other avenues of treatment opportunities — are left out / choked off / minimized.
The 2024 salary of Dr. Ugur Sahin, MD, CEO of BioNTech: $287 million dollars.
The 2024 salary of Dr. Albert Bourla, DVM, CEO of PfizerUSA (Pfizer): $24.6 million dollars.
Per: https://www.fiercepharma.com/special-reports/big-pharmas-10-highest-paid-ceos-2024, 16 June 2025.
Meanwhile, the Medical Tsunami of documented modRNA COVID-19 “vaccine”-induced or aggravated illnesses, injuries, or disabilities, among those who took / take these “vaccines”, rolls on. Meanwhile, the Medical Tsunami of documented modRNA COVID-19 “vaccine”-induced or related deaths among those who took these “vaccines” rolls on.
All persons — COVID-19 “vaccinated” or not — need to be following some type of SARS-CoV-2 spike protein detox / mitigation protocol. All persons — COVID-19 “vaccinated” or not — need to keep their immune system in the best shape possible.
All modRNA COVID-19 “vaccines” MUST be removed from the market and from use. Now.
THERE. MUST. BE. ACCOUNTABILITY.
THERE. MUST. BE. JUSTICE.
THERE. MUST. BE. TRUTH.
Peace, Good Energy, Respect: PAVACA
(Intellectual Property Notice: With the exception of linked articles and/or scientific papers that are available online, the ideas and conclusions in today’s offering are by PAVACA. Proper credit must be given to PAVACA for any other blog writer, podcaster, or social media outlet, in using the ideas or conclusions in today’s offering.)




































































































































